---
title: "BOAN BIOTECH's controlling shareholder plans to further transfer 38.5 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273244436.md"
description: "BOAN BIOTECH announced that its controlling shareholder LUYE PHARMA plans to arrange for its wholly-owned subsidiary Shandong Luye Pharma to further transfer 38.5 million H shares in the market on Thursday (22nd) as part of the proposed transfer. In December last year, LUYE PHARMA's wholly-owned subsidiary Luye Geneora issued several exchangeable preferred shares, allowing preferred shareholders to exchange the relevant shares for the existing H shares held by LUYE PHARMA, involving 100.5 million shares"
datetime: "2026-01-21T14:20:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273244436.md)
  - [en](https://longbridge.com/en/news/273244436.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273244436.md)
---

# BOAN BIOTECH's controlling shareholder plans to further transfer 38.5 million shares

BOAN BIOTECH (06955.HK) announced that its controlling shareholder LUYE PHARMA (02186.HK) plans to arrange for its wholly-owned subsidiary Shandong Luye Pharma to further transfer 38.5 million H shares to the market on Thursday (22nd) as part of the proposed transfer.

In December last year, LUYE PHARMA's wholly-owned subsidiary Luye Geneora issued several exchangeable preferred shares, allowing preferred shareholders to exchange the relevant shares for the existing H shares held by LUYE PHARMA, involving 100.5 million shares

### Related Stocks

- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [06955.HK](https://longbridge.com/en/quote/06955.HK.md)
- [02186.HK](https://longbridge.com/en/quote/02186.HK.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)

## Related News & Research

- [Luye Pharma Raises US$180 Million via Premium-Priced 2031 Convertible Bonds](https://longbridge.com/en/news/289390074.md)
- [Luye Pharma to Swap 2028 Convertible Debt with New 2031 Issue](https://longbridge.com/en/news/288643332.md)
- [CStone’s CS2009 Posts Strong ASCO Data as Company Prepares Global Phase III Trial](https://longbridge.com/en/news/288238438.md)
- [Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China Trial](https://longbridge.com/en/news/287276752.md)
- [Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial](https://longbridge.com/en/news/288172168.md)